Evidence mapPaperPMID 39741610Full record

ArticleCureus2024

Clinical Outcomes of Acute Pyelonephritis in Type 2 Diabetes Mellitus.

Priyatharicini Anandasekar, Thirumal Valavan Kaliaperumal, Swaminathan Ramasubramanian, Edwin Fernando Mervin

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Priyatharicini AnandasekarInternal Medicine, Stanley Medical College, Chennai, IND.
Thirumal Valavan KaliaperumalNephrology, Stanley Medical College, Chennai, IND.
Swaminathan RamasubramanianInternal Medicine, Government Medical College, Omandurar Government Estate, Chennai, IND.
Edwin Fernando MervinNephrology, Stanley Medical College, Chennai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Diabetes mellitus (DM) is a prevalent predisposing factor for urinary tract infections (UTIs). Among hospitalized patients with acute pyelonephritis, UTIs are more common, severe, and associated with worse outcomes, particularly in those with type 2 DM. Pyelonephritis in DM patients is more frequently bilateral and linked to greater complications, with 90% of emphysematous pyelonephritis (EMPN) and cystitis cases occurring in diabetic individuals. Objective This study aims to evaluate the clinical and microbiological profiles, treatment outcomes, and complications of acute pyelonephritis in patients with type 2 DM. Methods A six-month prospective observational study was conducted from March 2016 to August 2016 at Stanley Medical College and Hospital, Chennai, India. A total of 102 hospitalized patients presenting with symptoms suggestive of acute pyelonephritis were included. Data were collected using a clinical questionnaire and analyzed using IBM SPSS Statistics for Windows, Version 20.0 (Released 2011; IBM Corp., Armonk, New York, United States). Patients received culture-sensitive antimicrobial therapy, percutaneous drainage, and renal replacement therapy as required. Results Out of 102 patients, 80 (78.4%) had non-emphysematous pyelonephritis (NEMPN), and 22 (21.6%) had EMPN. The mean age was 55.2±10.9 years, with a female predominance of 63 (78.4%) participants.

Indexed as

acute pyelonephritisemphysematous pyelonephritisrenal dysfunctiontype 2 diabetes mellitusurinary tract infection

Identifiers

PMID39741610
PMCPMC11688164

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.